Jim Simons’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-615,900
| Closed | -$65.7M | – | 3799 |
|
|
2025
Q3 | $65.7M | Buy |
615,900
+468,500
| +318% | +$48.9M | 0.09% | 261 |
|
|
2025
Q2 | $13.9M | Buy |
147,400
+48,400
| +49% | +$3.58M | 0.02% | 882 |
|
|
2025
Q1 | $6.29M | Buy |
99,000
+83,500
| +539% | +$4.99M | 0.01% | 1281 |
|
|
2024
Q4 | $720K | Buy |
+15,500
| New | +$582K | ﹤0.01% | 2665 |
|
|
2024
Q3 | – | Sell |
-31,044
| Closed | -$449K | – | 3930 |
|
|
2024
Q2 | $449K | Buy |
+31,044
| New | +$453K | ﹤0.01% | 2744 |
|
|
2022
Q4 | – | Sell |
-210,100
| Closed | -$2.15M | – | 4449 |
|
|
2022
Q3 | $2.15M | Buy |
210,100
+181,900
| +645% | +$1.53M | ﹤0.01% | 1967 |
|
|
2022
Q2 | $118K | Buy |
+28,200
| New | +$121K | ﹤0.01% | 3805 |
|
|
2021
Q1 | – | Sell |
-24,800
| Closed | -$174K | – | 3744 |
|
|
2020
Q4 | $174K | Buy |
+24,800
| New | +$168K | ﹤0.01% | 3167 |
|
|
2020
Q3 | – | Sell |
-21,410
| Closed | -$100K | – | 3722 |
|
|
2020
Q2 | $100K | Buy |
+21,410
| New | +$99.1K | ﹤0.01% | 3276 |
|
|
2020
Q1 | – | Sell |
-12,500
| Closed | -$72K | – | 3839 |
|
|
2019
Q4 | $72K | Buy |
+12,500
| New | +$54.6K | ﹤0.01% | 3357 |
|
|
2019
Q3 | – | Sell |
-10,300
| Closed | -$53K | – | 3734 |
|
|
2019
Q2 | $53K | Sell |
10,300
-1,400
| -12% | -$8.54K | ﹤0.01% | 3449 |
|
|
2019
Q1 | $76K | Buy |
+11,700
| New | +$76.2K | ﹤0.01% | 3331 |
|
Other funds holding VRNA
Jim Simons's VRNA Position: Q4 2025 in Review
Jim Simons sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 615,900 shares — an estimated $65.7M sold.
Jim Simons first reported a position in VRNA in Q1 2019 and held it in 12 quarters. The position peaked at $65.7M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.
- Jim Simons reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
- Jim Simons sold 615,900 Verona Pharma shares in Q4 2025, an estimated $65.7M.
- Jim Simons first reported a position in Verona Pharma in Q1 2019 and held it in 12 quarters.
- Jim Simons's Verona Pharma position peaked at $65.7M in Q3 2025.
- 1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.
Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.